CClinicalTrials.gg
CompletedNCT01443897Updated Sep 30, 2011

Effect of Consumption of Post-harvest UV-B Treated Mushrooms on Vitamin D Status of Healthy Adults

An interventional study of 1,000 IU vitamin D2 and placebo capsule in Vitamin D Deficiency, sponsored by USDA, Western Human Nutrition Research Center. Completed at 1 site in United States. Open to participants aged 20 Years to 59 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2011-09-30.

Sponsored by USDA, Western Human Nutrition Research Center · Not applicable, Interventional, and Basic science

Phase
Not applicable
Study type
Interventional
Enrollment
48
Allocation
Randomized
Ages
20 Years to 59 Years
Sex
All
01

Study summary

This study will investigate whether mushrooms treated with ultraviolet (UV) light to increase their vitamin D2 content are actually a good source of vitamin D when consumed daily with a meal (lunch). The mushrooms will be provided cooked along with a meal which will be a standard, pre-packaged frozen meal. We also hope to learn if the resulting improvement in vitamin D status affects the immune system by decreasing it's level of activation, which may be abnormally elevated in vitamin D deficiency.

Read the detailed description

Volunteers will be asked to consume a standard meal (lunch) containing one serving of mushrooms daily for six weeks (7 days per week). With the meal, they will also need to take one capsule. The capsule will be either a placebo or will contain vitamin D. The purpose of the vitamin D in the capsule is to determine if the vitamin D from the mushrooms is absorbed as well as vitamin D from a capsule. The total dose of vitamin D that volunteers will receive each day from mushrooms and capsule together will always be the same and will be one of three doses: (1) little or no vitamin D (placebo); (2) 400 IU, which is near the current recommended intake and (3) 1,000 IU, which is up to five-fold higher than the current recommended intake, depending on your age. Both levels of vitamin D are safe. In addition to consuming the meals and taking the capsules, up to 20 mL (4 teaspoons) of blood will be drawn at three times during the study just before the mushroom-containing lunch is provided: (1) at the beginning of the study before the first meal; (3) after three weeks; (3) at the end of the study. The purpose of the blood draw is to measure vitamin D in your blood and to measure the level of activation of your immune system by measuring markers of immune activation.

02

Conditions studied

  • Vitamin D Deficiency

Browse trials for

Keywords

  • Vitamin D
03

In context

Vitamin D Deficiency

772 studies on the registry are indexed under Vitamin D Deficiency; 61 are open to participants now.

This study's enrollment of 48 is below the median of 77 across 564 interventional studies indexed under Vitamin D Deficiency.

Browse Vitamin D Deficiency studies →

Lead sponsor

USDA, Western Human Nutrition Research Center is the lead sponsor of 53 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years to 59 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • willing to consume a lunch meal 7 days per week for 6 weeks containing mushrooms
  • willing to stop eating other sources of mushrooms
  • willing to discontinue taking vitamin D and other dietary supplements
  • estimated low vitamin D status based on dietary questionnaire, skin reflectance, and sun behavior

Exclusion criteria

Exclusion Criteria:

  • women who are pregnant or breastfeeding
  • volunteers with anemia
  • volunteers with evidence of underlying disease affecting vitamin D metabolism
  • volunteers taking medications altering vitamin D metabolism
05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Investigator)
Enrollment
48 participants (actual)

Study arms

  • Placebo comparator
    Group 1

    Untreated mushrooms plus placebo capsule.

    Dietary Supplement: placebo capsule · Other: mushrooms

  • Experimental
    Group 2

    UVB-treated mushrooms (400 IU vitamin D2 per serving) plus placebo capsule.

    Dietary Supplement: placebo capsule · Other: UVB-treated mushrooms, 400 IU vitamin D2

  • Experimental
    Group 3

    UVB-treated mushrooms (1,000 IU vitamin D2 per serving) plus placebo capsule.

    Dietary Supplement: placebo capsule · Other: UVB-treated mushrooms, 1,000 IU vitamin D2

  • Experimental
    Group 4

    Untreated mushrooms plus 1,000 IU Vitamin D2 in capsule

    Dietary Supplement: 1,000 IU vitamin D2 · Other: mushrooms

Interventions

  • Dietary supplement1,000 IU vitamin D2

    capsule containing 1,000 IU vitamin D2

  • Dietary supplementplacebo capsule

    0 IU vitamin D2

  • Othermushrooms

    untreated button mushrooms, obtained from Monterey Mushrooms, Monterey, CA

  • OtherUVB-treated mushrooms, 400 IU vitamin D2

    UVB-treated button mushrooms, 400 IU vitamin D2 per 1/2 cup serving, obtained from Monterey Mushrooms, Monterey, CA

  • OtherUVB-treated mushrooms, 1,000 IU vitamin D2

    UVB-treated button mushrooms, 1,000 IU vitamin D2 per 1/c serving, obtained from Monterey Mushrooms, Monterey, CA

06

What researchers measure

Primary outcomes

  1. Change in serum Vitamin D2

    Serum vitamin D 2 will be measured in serum.

    Time frame: 0, 3 and 6 weeks

Secondary outcomes

  1. Change in serum markers of inflammation

    Measure serum cytokines, chemokines, and neopterin.

    Time frame: 0, 3, and 6 weeks

07

Study locations

1 site
  • USDA, ARS, Western Human Nutrition Research Center
    Davis, California 95616, United States
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 30, 2011, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01443897
Lead sponsor
USDA, Western Human Nutrition Research Center
Responsible party
Sponsor
First posted
Sep 30, 2011
Start date
May 2010
Primary completion
Nov 2010
Completion
Jun 2011
Last update
Sep 30, 2011

Study contacts

Charles B Stephensen, PhD
principal investigator · USDA, ARS, Western Human Nutrition Research Center

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2011. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion